This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-017224-naromr0a | the Will Terrorists Turn to Poison? |
| cord-007188-tcq8lnwg | 3J? |
| cord-022521-r72jtoso | : What is the current treatment and what are the challenges? |
| cord-004986-en7taikk | Approximativement 30? |
| cord-004986-en7taikk | et certains auteurs sceptiques sugg6rent que ces diarrh6es seraient dues? |
| cord-004986-en7taikk | inf6rieur? |
| cord-009561-pg4jmvw4 | Virus isolated from the brain of a patient with multiple sclerosis Transmission experiments with multiple sclerosis Decreased percentage of polyrnorphonuclear neutrophils in mouse peripheral blood after inoculation with material from multiple sclerosis patients Fusion of culcured multiple sclerosis brain cells with indicator cellspresence of nucleocapsids and virions and isolation of parainfluenza- type virus Viruses in multiple sclerosis? |
| cord-009561-pg4jmvw4 | What have we learned from other demyelinating diseases? |
| cord-016690-3gsq724l | CT image demonstrations of HIV- seropositive tuberculosis and their relationship with CD4+ T- lymphocyte count Positron emission tomography of 18FDG uptake in localized pulmonary infl ammation Penicilliosisde Rhizomys sinensis Accumulation of nuclear mitochondrial DNA in the frontal cortex cells of patients with HIVassociated neurocognitive disorders Imaging fi ndings of AIDS complicated with pulmonary rhodococcus equi infection and correlated with pathology Pulmonary toxoplasmosis? |
| cord-018070-js9vvsud | : Are there any sex workers in China? |
| cord-018070-js9vvsud | Why develop and support women's organizations in providing legal aid in China? |
| cord-009338-zc88lsls | In 1984 I look forward to further definition of this relationship which may help to answer the several puzzling questions that confront clinicians, such as why does this child develop encephalitis with Epstein- Barr virus and this one not, or why does this child die with an overwhelming bacteremia whereas the majority of individuals do not, or why does poliovirus produce paralysis in certain individuals whereas the vast majority of exposed and infected individuals either have asymptomatic infection or nonparalytic illness? |
| cord-009338-zc88lsls | What's in store for 1984? |
| cord-009338-zc88lsls | Will we discover new infectious diseases or the causes of some which have eluded us thus far? |
| cord-309489-ubf55eux | Polio: The Final Assault? |
| cord-017675-in9r33ww | Do human rights matter to health? |
| cord-017675-in9r33ww | HIV Risk Behavior? |
| cord-017675-in9r33ww | How much revenue will a pharmaceutical company generate in each of the following scenarios? |
| cord-017506-t86v3zw3 | How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? |
| cord-017506-t86v3zw3 | In fl uence of chronic alcohol abuse on body weight and energy metabolism: is excess ethanol consumption a risk factor for obesity or malnutrition? |
| cord-280823-i1n8mu8b | Debates about McKeown's thesis have persisted in light of the question, are"public health ends better served by targeted interventions or by broadbased efforts to redistribute the social, political, and economic resources that determine the health of populations? |
| cord-280823-i1n8mu8b | How do we then differentiate theory from recommendations for healthcare practice? |
| cord-316534-ep7ezoko | The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? |
| cord-021121-qgqzr6n2 | Doch was genau ist Global Health? |
| cord-021121-qgqzr6n2 | Doch wirken die außen- und sicherheitspolitischen Motive maßgeblicher Staaten darin nicht als Störfaktoren? |
| cord-021121-qgqzr6n2 | Du weißt, dass du ein großes Problem in deinem Land hast?" |
| cord-333405-ji58jbct | The origins of acquired immune deficiency viruses: where and when? |
| cord-005882-iodfgzjf | ( World Health Organization Is the development of a new tuberculosis vaccine possible? |
| cord-005882-iodfgzjf | A Modeling Study A waxy tale by Mycobacterium tuberculosis Intracelluar models of Mycobacterium tuberculosis infection Mycobacterium tuberculosis: the indigestible microbe CD8 T cells in tuberculosis CD1 and tuberculosis gamma/ delta and other unconventional T lymphocytes: What do they see and what do they do? |
| cord-005882-iodfgzjf | Could AIDS and tuberculosis vaccines be given together? |
| cord-005882-iodfgzjf | Die Schutzimpfung gegen Tuberkulose mit"BCG Immune control of HIV-1 after early treatment of acute infection Guidelines for using antiretroviral agents among HIV- infected adults and adolescents Can Population Differences Explain the Contrasting Results of the Mwanza, Rakai, and Masaka HIV/ Sexually Transmitted Disease Intervention Trials?: |
| cord-005882-iodfgzjf | How can immunology contribute to the control of tuberculosis? |
| cord-324056-cvvyf3cb | Global governance in health-do historical experiences of industrialized countries teach any lessons? |
| cord-324056-cvvyf3cb | The International bank for reconstruction and development/ the world bank Millennium development goals for health: what will it take to accelerate progress? |
| cord-300467-zht8olyh | Time to End the Neglect? |
| cord-104491-uu2rbtem | We posed an audacious question: Should n't HIV testing be a mandatory part of obstetric care? |
| cord-104491-uu2rbtem | Where Have All the “ AIDS Babies ” Gone? |
| cord-000130-dqqcajjd | Can we do better, quicker? |
| cord-000130-dqqcajjd | Can we optimally spend our way out of the HIV/ AIDS epidemic? |
| cord-000130-dqqcajjd | Can we spend our way out of the AIDS epidemic? |
| cord-000130-dqqcajjd | Can we then seize the moment and halt this epidemic now? |
| cord-000130-dqqcajjd | Can we work together to build a World Halting AIDS Model( WHAM) that would permit us to estimate the quickest way to halt HIV/ AIDS, monitor our success, and adjust our strategy as we go? |
| cord-000130-dqqcajjd | authors: Smith?, Robert J; Gordon, |
| cord-284128-3obc5k5u | Italy Healthcare is not universal if undocumented migrants are excluded Is forced migration a barrier to treatment success? |
| cord-284128-3obc5k5u | What is required to end the AIDS epidemic as a public health threat by 2030? |
| cord-251939-dvbua4pf | Coverage of Selected Services for HIV/ AIDS Prevention, Care and Support in Low and Middle- income Countries in Interventions to reduce HIV/ AIDs stigma: what have we learned? |
| cord-251939-dvbua4pf | So, why are the responses to the prospective'storm'low, slow, and fragmented? |
| cord-251939-dvbua4pf | Why is there little appre- ciation among the leaders that the disease might take a heavy toll if left unchecked? |
| cord-302403-kahi8cbc | Is this tuberculosis, toxoplasmosis, cryptococcosis, or viral or bacterial infection? |
| cord-017782-dtveihrj | How can we resolve the issue of two HIV serology tests taken at separate times in the same subject being false positive? |
| cord-017782-dtveihrj | What is the effect of life expectancy with late treatment initiation for HIV disease? |
| cord-017782-dtveihrj | What lessons can we learn from these cases? |
| cord-017782-dtveihrj | Would an earlier diagnosis by 1 year and assuming institution of ART then, affected the outcome as to lifespan and quality of life? |
| cord-275880-d53xe5oh | Are dental offices prepared to treat these potentially infected patients? cord-275880-d53xe5oh What will come of this pandemic? cord-275880-d53xe5oh Will dentistry accept the advances or continue our history of fighting change? cord-332856-96z48gpg Idiopathisches multiples Pigmentsarkom der Haut Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes Kaposi's sarcoma in renal allograft recipients Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications Kaposi's sarcoma in homosexual men- a report of eight cases Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? cord-332856-96z48gpg Treatment of malaria from monotherapy to artemisinin- based combination therapy by health professionals in rural health facilities in southern Cameroon UMSP sentinel site malaria surveillance report Reactivation of Kaposi's sarcoma- associated herpesvirus by natural products from Kaposi's sarcoma endemic regions Kaposi sarcoma and quinine: a potentially overlooked triggering factor in millions of Africans Re- evaluation of antimalarials in treating rheumatic diseases: re- appreciation and insights into new mechanisms of action Antibody response to preexposure human diploid- cell rabies vaccine given concurrently with chloroquine Does quinine facilitate AIDS? cord-001079-v01vwu00 , TDF? cord-001079-v01vwu00 : what's new? cord-001079-v01vwu00 Grupo de Estudio del SIDA 04/98 Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxis Pneumocystis carinii pneumonia after the discontinuation of secondary prophylaxis Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus- infected patients: a randomized trial by the CIOP Study Group Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4? cord-001079-v01vwu00 In a small study in Thailand, a higher dose of fluconazole( 800 mg/ day) combined with AmB- D( 0.7 mg/ kg/ day) was more effective than monotherapy with AmB- D alone or a regimen of AmB- D? fluconazole( 400 mg/ day). cord-001079-v01vwu00 Other combination therapies( e.g. fluconazole? cord-001079-v01vwu00 is prophylaxis still indicated? cord-001079-v01vwu00 results of an open, randomized, multicenter clinical trial Immune recovery under highly active antiretroviral therapy is associated with restoration of lymphocyte proliferation and interferon- gamma production in the presence of Toxoplasma gondii antigens Restoration of Toxoplasma gondii- specific immune responses in patients with AIDS starting HAART Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel Restoration of cytomegalovirusspecific CD4? cord-294441-nehorqhi What can natural infection of African monkeys with simian immunodeficiency virus tell us about the pathogenesis of AIDS? cord-306701-hs9cfdsu Health Access and Quality based o mortality from causes amenable to personal healthcare in 195 countries and territories, 1990- 2015: a novel analysis from the Global Burden of Disease Study What will become of me if they take this away? cord-306701-hs9cfdsu It is astounding that the 2017 ratio for SADC was lower than the ratio experienced in OECD member states 30 years prior, a period during which there was no widespread use of ART or secondary prophylaxis against opportunistic infections? cord-306701-hs9cfdsu What is required to end the AIDS epidemic as a public health threat by 2030? cord-342076-3a6aky7i Jilin People's Publishers Quality assurance in the HIV/ AIDS laboratory network of China Joint United Nations Programme on HIV/ AIDS, World Health Organization Geneva: World Health Organization and Joint United Nations Programme on HIV Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV? cord-342076-3a6aky7i The China Stigma Index Report Evaluation of effect of community- based HIV/ AIDS interventions among men who have sex with men in eighteen cities, China Which Chinese men who have sex with men miss out on HIV testing? cord-254187-dcdc6sqi : cord-254187-dcdc6sqi authors: Kimball, AM; Thant, Myo title: “ What, me worry? ” cord-254187-dcdc6sqi Global business surveybusiness and AIDS: commitment and action? cord-254187-dcdc6sqi The global epidemic has shown its inexorable nature in community afterWhat, me worry?" |
| cord-254187-dcdc6sqi | Why such complacency? |
| cord-254187-dcdc6sqi | community, country after country; will it now be business after business? |
| cord-322581-v96k4yxg | The impact of an intervention to change health workers'HIV/ AIDS attitudes and knowledge in Nigeria: a controlled trial Nurses knowledge, attitude and willingness to take care for HIV/ AIDS patients in Bhutan Challenges for future research: providing evidence for health- care education Moving nursing research forward towards a stronger impact on health care practice? |
| cord-322581-v96k4yxg | family or patient's first? |
| cord-322581-v96k4yxg | key: cord-322581-v96k4yxg authors: Mockiene, Vida; Suominen, Tarja; Välimäki, Maritta; Razbadauskas, Arturas; Caplinskas, Saulius; Martinkenas, Arvydas title: Nurses'willingness to take care of people living with human immunodeficiency virus/ acquired immunodeficiency syndrome( HIV/ AIDS) — does a teaching intervention make a difference? |
| cord-104490-t42eccng | A natural follow- up question would be; how have these educational commitments and interventions affected health outcomes so far? |
| cord-104490-t42eccng | Consequently, we ask: how exactly have global education efforts to improve health performed so far? |
| cord-104490-t42eccng | What was the effect of the West African Ebola outbreak on health programme performance, and did programmes recover? |
| cord-104490-t42eccng | Why then are educational efforts still failing to address the health challenges of young girls and women, as we have observed in the HIV/ AIDS epidemic and, most recently, the EVD crisis[ 12]? |
| cord-293379-c4qdmkw5 | Does HIV variation matter? |
| cord-293379-c4qdmkw5 | Lentivirus tropism and pathogenesis Are RNA viruses adapting or merely changing? |
| cord-293379-c4qdmkw5 | Who would have thought a few years ago that men imbued with their traditional social customs would readily come forward to take part in randomized controlled trials of adult circumcision? |
| cord-293379-c4qdmkw5 | Will the drop in AIDS mortality owing to antiretroviral therapy( Fig. 1) be maintained so that people on treatment can expect a normal life span? |
| cord-297257-lzybfwc2 | Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry[ v1; ref status: awaiting peer review Evaluation of Ebola virus inhibitors for drug repurposing Lack of protection against Ebola virus from chloroquine in mice and hamsters Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure Persistent immune activation in chronic HIV infection: do any interventions work? |
| cord-297257-lzybfwc2 | early HIV infection predicts subsequent CD4+ T- cell changes independent of viral load Relationship between T cell activation and CD4+ T cell count in HIV- seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy Immune activation and HIV persistence: considerations for novel therapeutic interventions Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-297257-lzybfwc2 | interferon: implication for T- cell activation Hydroxychloroquine preferentially induces apoptosis of CD45RO+ effector T cells by inhibiting autophagy: a possible mechanism for therapeutic modulation of T cells A cure for AIDS: a matter of timing? |
| cord-300793-tuq8z6gm | The challenge of emerging and re- emerging infectious diseases Environmental and social influences on emerging infectious diseases: past, present and future Mortality trends and setbacks: global convergence or divergence? |
| cord-300793-tuq8z6gm | The injection century: massive unsterile injections and the emergence of human pathogens Mortality before and after HIV infection in the complete UK population of haemophiliacs Transmission of West Nile virus through blood transfusion in the United States in 2002 Transmission of West Nile virus from an organ donor to four transplant recipients Cell and molecular biology of simian virus 40: implications for human infections and disease SV40 in human cancers- an endless tale? |
| cord-300793-tuq8z6gm | What have we learnt from SARS? |
| cord-258792-4lakgpxp | The Scandal over Taiwan', International Herald Tribune Health, Civilisation and the State: A History of Public Health from Ancient to Modern Times Building Our New Geat Wall-On the Great Spirit of Resisting and Attacking SARS', People's Daily, 15 May Is SARS China's Chernobyl or Much Ado About Nothing? |
| cord-258792-4lakgpxp | This leads to the following questions: What were the factors that inhibited and then facilitated the collaboration during the outbreak? |
| cord-258792-4lakgpxp | What eventually brought China back to'business as usual'after the outbreak? |
| cord-258792-4lakgpxp | What ultimately motivates the government's agenda and actions towards infectious diseases? |
| cord-021742-sdz6d1r5 | A more aggressive approach? |
| cord-021742-sdz6d1r5 | A systematic review Chest tubes: indications, techniques, management and complications Recurrent re- expansion pulmonary edema Chest tube removal: End- inspiration or end- expiration? |
| cord-021742-sdz6d1r5 | Common or uncommon? |
| cord-021742-sdz6d1r5 | Do bullae indicate a predisposition to recurrent pneumothorax? |
| cord-021742-sdz6d1r5 | Is spirometry a predictor? |
| cord-021742-sdz6d1r5 | Low diagnostic yield with routine chest roentgenograms Safety of the transbronchial biopsy in outpatients Is routine chest radiography after transbronchial biopsy necessary? |
| cord-021742-sdz6d1r5 | The pathophysiology of progressive tension pneumothorax Pathogenesis of spontaneous pneumothorax with special reference to the ultrastructure of emphysematous bullae Infl uence of height on the risk of spontaneous pneumothorax Familial spontaneous pneumothorax Familial primary spontaneous pneumothorax consistent with true autosomal dominant inheritance Spontaneous pneumothorax in Norfolk Time relation between sale of cigarettes and the incidence of spontaneous pneumothorax Smoking and the increased risk of contracting spontaneous pneumothorax Fraser and Paré's Diagnosis of Diseases of the Chest Spontaneous pneumothorax in chronic obstructive pulmonary disease: Complications, treatment and recurrences Diseases of the pleural space Complications of attempted central venous injection performed by drug abusers Man's worst enemy- himself Spontaneous bilateral pneumothorax in drug addicts Alternate therapy for traumatic pneumothorax in"pocketshooters Pneumothorax in drug abusers: An urban epidemic? |
| cord-295290-hs5ntlok | An AIDS- related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV- l Protection from experimental autoimmune thyroiditis conferred by a monoclonal antibody to T- cell receptor from a cytotoxic hybridoma specific for thyroglobulin Immunization with a synthetic T- cell receptor Vregion peptide protects against experimental autoimmune encephalomyelitis Arthritis induced by a T- lymphocyte clone that responds to Mycobucterium tuberculosis and to cartilage proteoglycans Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis Inhibition of antigen- induced lymphocyte proliferation by Tat protein from HIV- l Adoptive transfer of EAE- like lesions from rats with coronavirus- induced demyelinating encephalomyelitis HIV- l gpl20-mediated immune suppression and lymphocyte destruction in the absence of viral infection Networks of automata and biological organization HIV and HLA similarity HIVinfected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells MHC- restricted depletion of human myetin basic protein- reactive T cells by T cell vaccination Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphocytic retrovirus Virus- triggered AIDS: a T- cellmediated immunopathology? |
| cord-295290-hs5ntlok | Does the HIV envelope induce a chronic graft- versus- hostlike disease? |
| cord-295290-hs5ntlok | No lights, no camera, just facts Loss of envelope antigens of HTLV- III/ LAV, a factor in AIDS pathogenesis? |
| cord-295290-hs5ntlok | The panergic amnesia hypothesis T cell vaccination of HIV- seropositives: a therapeutic test for the autoimmune component of AIDS Preface, in"Theories of immune networks Introduction to immune networks Paradoxical effects of suppressor T cells in the onset of adjuvant arthritis: neural network analysis Can AIDS be prevented by T- cell vaccination? |
| cord-341503-3cvtoc2j | COVID-19 conspiracy theories: was SARS- CoV-2 made in a lab? |
| cord-341503-3cvtoc2j | Does discrimination breed mistrust? |
| cord-341503-3cvtoc2j | Whose responsibility is it to dismantle medical mistrust? |
| cord-325300-wawui0fd | What is a reasonable explanation of the occurrence; is there a previous pattern, with the present episode a recurrence or new event? |
| cord-325300-wawui0fd | What steps are needed to prevent spread and recurrence of the disease? |
| cord-316904-g7dli0a8 | 112 Is there a role for leptin? |
| cord-316904-g7dli0a8 | As these cytokines do not appear to cross the blood- brain barrier in significant amounts, how can these cytokines be acting at the CNS level? |
| cord-316904-g7dli0a8 | What are mechanisms( and mediators) by which anorexia and hypermetabolism are produced? |
| cord-316904-g7dli0a8 | What, therefore, would be the cause for muscle wast- ing in AIDS? |
| cord-316904-g7dli0a8 | pilot studies Pentoxifylline therapy in HIV seropositive subjects with elevated TNF Pentoxifylline for treatment of cancer anorexia and cachexia? |
| cord-264699-l8db5gll | Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy Metabolic complications associated with antiretroviral therapy Metabolic disorders among HIV- infected patients treated with protease inhibitors: a review HIV- associated lipodystrophy syndrome Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS- related insulin resistance/ lipodystrophy syndrome? |
| cord-264699-l8db5gll | The hypothalamic- pituitary- adrenal axis and immune- mediated inflammation Effectiveness of prolonged glucocorticoid treatment in acute respiratory distress syndrome: the right drug, the right way? |
| cord-263438-9ra94uda | At the end of the victory over SARS, the nagging question therefore remains: even after the impressive efforts at rearmament since 1992, how prepared is the international community for upcoming emerging diseases? |
| cord-263438-9ra94uda | For example, should priority be given to those diseases for which the human immune response gives grounds for optimism thaton the basis of historical experience-a safe and effective vaccine can be developed( e.g. influenza and dengue)? |
| cord-263438-9ra94uda | Have we been forever changed? |
| cord-263438-9ra94uda | Or should other strategies be followed with respect to diseases for which the human immune response makes the development of a vaccine a far more arduous and unpredictable endeavor( e.g. cholera and malaria)? |
| cord-263438-9ra94uda | The Surgeon General's Report on Health Promotion and Disease Prevention Health, Human Rights, and the New War on the Poor Infections and Inequalities: The Modern Plagues Could a tuberculosis epidemic occur in London as it did in New York? |
| cord-263438-9ra94uda | What could possibly have led to such overweening confidence in the power of science, technology, and civilization to vanquish communicable disease? |
| cord-263438-9ra94uda | Will we be ready when it returns? |
| cord-252039-732z92dd | Are any drugs available that can cure or safely treat persons once they've become infected? |
| cord-252039-732z92dd | But what can we say about the public health responses that were undertaken in the years following the 1918- 1919 influenza pandemic, after the immediate threat had passed? |
| cord-252039-732z92dd | Do we have a test that can accurately diagnose infection? |
| cord-252039-732z92dd | How long will it take for scientists to develop an effective vaccine that can prevent disease acquisition? |
| cord-252039-732z92dd | Trust for America's Health Simple, effective but out of reach? |
| cord-252039-732z92dd | What can history teach us about successful responses to past infectious disease pandemics? |
| cord-252039-732z92dd | Why? |
| cord-016829-37i1bn9m | : Why are Donors not Working Together? |
| cord-016829-37i1bn9m | A Response to Joseph Hanlon's Recent Article, Donor Concern Over IMF Cap on Aid Increases AIDS: Free Access to Treatment, a Public Health Necessity or an Economic Heresy? |
| cord-016829-37i1bn9m | Are we spending too much on HIV? |
| cord-016829-37i1bn9m | The Evolving HIV Epidemic: What Have We Learned Since the MAP Began? |
| cord-016829-37i1bn9m | The New International Aid Architecture: New Players, New Challenges Strengthening Partnerships in HIV Monitoring and Evaluation: How Joint Missions Build and Strengthen Partnerships to Support the Realization of National M&E systems Global Fund Responsiveness to Faith- based Organizations IMF must Adapt and Downsize or die Socioeconomic obstacles to HIV prevention and treatment in developing countries: The roles of the international monetary fund and the World bank Funding the Response to AIDS: Why are Donors not Working Together? |
| cord-016829-37i1bn9m | What is Business Doing? |
| cord-016829-37i1bn9m | Why are Donors not Working Together? |
| cord-016829-37i1bn9m | Why are Donors not Working Together? |
| cord-016829-37i1bn9m | Why are Donors not Working Together? |
| cord-016829-37i1bn9m | Why are Donors not Working together? |
| cord-016718-cxn1ewfw | Do you remember how I distrusted and doubted you when we met for the first time? |
| cord-016718-cxn1ewfw | Does n't it reflect prejudice ingrained in our values? |
| cord-016718-cxn1ewfw | I think that only when we create a better recovery? |
| cord-016718-cxn1ewfw | She asked;'Who is paying attention to the people who are in fear? |
| cord-016718-cxn1ewfw | Then why do n't I use my last time to make friends and contribute to the society to build a better afterlife? … |
| cord-016718-cxn1ewfw | Who does n't want to live healthily and happily? |
| cord-016718-cxn1ewfw | environment and cultural? |
| cord-016718-cxn1ewfw | … I wonder why a patient tries so hard to try to prove his innocence? |
| cord-017061-vk55gm0j | How are the ethical issues in the context of TB similar to, or different from, those that arose in the context of HIV/ AIDS? |
| cord-017061-vk55gm0j | How important are these liberties- and are they outweighed by public health benefits requiring coercion? |
| cord-017061-vk55gm0j | How should the social aim to promote public health be balanced against the aim to protect human rights and liberties in the context of diseases that are to varying degrees contagious, dangerous or deadly? |
| cord-017061-vk55gm0j | Is it appropriate for developed countries to shift costs for their public health onto the overburdened health systems of other, less well- resourced, countries? |
| cord-017061-vk55gm0j | The challenge of global health Public health law and ethics Is there a duty not to infect others? |
| cord-017061-vk55gm0j | The distribution of biomedical research resources and international justice XDR- TB in South Africa: back to TB sanatoria perhaps? |
| cord-017061-vk55gm0j | The health of nations: infectious disease, environmental change, and their effects on national security and development Diminishing returns? |
| cord-017061-vk55gm0j | The power of pills: social, ethical, and legal issues in drug development, marketing and pricing Tuberculosis, non- compliance and detention for the public health Asylum and migration working paper 1: migration, public health and compulsory screening for TB and HIV Case studies in public health ethics Ethics, prevention, and public health Is sickness a crime? |
| cord-017061-vk55gm0j | To what extent should someone who knows she has been exposed to TB limit her interactions with others afterwards? |
| cord-017061-vk55gm0j | Would it be wrong to deprive control arm subjects of second- line drugs if they would not receive them if they did not participate in the study in question- given the poverty situation in the local context? |
| cord-017061-vk55gm0j | no time for denial or complacency TB control, poverty, and vulnerability in Delhi Are there characteristics of infectious disease that raise special ethical issues? |
| cord-268712-rxdw553c | A bio- psychosocial evolutionary view of the role of the traumatic stress response in the emergence of pathology and/or growth Assessing spiritual growth and spiritual decline following a diagnosis of cancer: Reliability and validity of the spiritual transformation scale A better world or a shattered vision? |
| cord-268712-rxdw553c | A cross validation study that extends the generality of"benefit finding"in cancer patients with chronic disease Posttraumatic stress disorder in response to HIV infection Psychosocial and sociodemographic correlates of benefit- finding in men treated for localised prostate cancer Still stable after all this …? |
| cord-268712-rxdw553c | Can crisis lead to personal life transformation? |
| cord-268712-rxdw553c | Construing benefits from adversity: Adaptational significance and dispositional underpinnings Medical illness and positive life change: Can crisis lead to personal life transformation? |
| cord-268712-rxdw553c | Positive changes in the aftermath of crisis Posttraumatic growth in prostate cancer survivors and their partners Is finding something good in the bad always good? |
| cord-268712-rxdw553c | Temporal comparison in coping with severe and chronic disease Posttraumatic growth and group- based interventions for persons dealing with cancer: What have we learned so far? |
| cord-268712-rxdw553c | The problem in using fixed- effects models of meta- analysis on realworld data Is the meta- analysis of correlation coefficients accurate when population effect sizes vary? |
| cord-274061-ynqxgyw6 | Are we prepared to deal with potential threats from bioterrorism agents? |
| cord-274061-ynqxgyw6 | Does it make sense to screen all blood donations when risks of babesiosis and dengue are seasonal and geographical? |
| cord-274061-ynqxgyw6 | How much effort should be expended to prepare for an outbreak of chikungunya virus that might never happen? |
| cord-274061-ynqxgyw6 | More generally, as we become increasingly proactive in addressing infectious risks, are we misdirecting resources that could be better spent to improve blood safety in other ways? |
| cord-274061-ynqxgyw6 | What changes to the current paradigm of donor screening and testing can be considered when pathogen reduction becomes available for all blood components? |
| cord-274061-ynqxgyw6 | respiratory syndrome coronavirus in the absence of studies to establish the presence or absence of viremia in the course of the infections? |
| cord-312194-1jiaghrb | What do you know about the transmission of the virus? cord-312194-1jiaghrb What do you understand by being prepared to provide oral health care during the pandemic? |
| cord-312194-1jiaghrb | Why is this pandemic relevant to oral health care? cord-312194-1jiaghrb But at what cost? I'm not sure it is even working the way it should. cord-312194-1jiaghrb COVID-19 information for dental patients Member checking: a tool to enhance trustworthiness or merely a nod to validation? cord-312194-1jiaghrb How do we balance tensions between COVID-19 public health responses and stigma mitigation? cord-312194-1jiaghrb Interview questions included but were not limited to the following: 1)What do you know about the COVID-19 outbreak? |
| cord-312194-1jiaghrb | Is n't that the same history behind HIV back in the 80s, from slaughtering monkeys in the[ African] jungles, that was transmitted to us? |
| cord-312194-1jiaghrb | What will be the new normal for the dental industry? |
| cord-009269-6fs0f4b7 | ( As We Now Use the Word)?', Unpublished manuscript Disease and Globalized Anarchy: Theoretical Perspectives on the Pursuit of Global Health |
| cord-009269-6fs0f4b7 | : Is universal access to antiretroviral drugs an emerging international norm? |
| cord-009269-6fs0f4b7 | Can Ministries of Health Support Primary Health Care? |
| cord-009269-6fs0f4b7 | How has this new norm emerged and why has it emerged now? |
| cord-009269-6fs0f4b7 | Is It Losing Its Influence? |
| cord-009269-6fs0f4b7 | Mahler, during the promotion of Health for All by 2000, held the same position as Lee, so what explains the difference? |
| cord-009269-6fs0f4b7 | The Global Compact: Shifting the Politics of International Development? |
| cord-009269-6fs0f4b7 | They answer the question'who am I?' |
| cord-009269-6fs0f4b7 | Versus PHC? |
| cord-009269-6fs0f4b7 | What explains the difference? |
| cord-009269-6fs0f4b7 | What prevented the norm of universal primary health care from being adopted and internalized by the international community? |
| cord-009269-6fs0f4b7 | Which Norms Matter? |
| cord-323261-1of5ertf | After the Global Fund Investment in HIV/ AIDS programs: does it help strengthen health Systems in Developing Countries? |
| cord-323261-1of5ertf | Considering the regime type of the government, allowing the growth of local NGOs would in turn potentially attenuate the supremacy of the Chinese Communist Party( CCP) in ruling the country or erode the autonomy of the state, why the Chinese government tolerated, allowed, or even encouraged the growth of NGOs in fixing HIV/ AIDS problems, especially the epidemic has been viewed as a politically sensitive issue in China? |
| cord-323261-1of5ertf | How can one account for and understand the phenomenon? |
| cord-323261-1of5ertf | How is health a security issue? |
| cord-323261-1of5ertf | International Community Foundation Is China's new overseas NGO management law sounding the death knell for civil society? |
| cord-323261-1of5ertf | Politics, responses and issues Securitizing infectious disease Should HIV/ AIDS be securitized? |
| cord-323261-1of5ertf | The ethical dilemmas of linking HIV/ AIDS and security where are the links? |
| cord-323261-1of5ertf | United Nations General Assembly United Nations General Assembly AIDS and security: where are we now? |
| cord-323261-1of5ertf | key: cord-323261- 1of5ertf authors: Lo, Catherine Yuk- ping title: Securitizing HIV/ AIDS: a game changer in state- societal relations in China? |
| cord-350569-dtxtjtfo | Does Christman, who criticises Frankfurtian theories of autonomy, provide a more realistic perspective? |
| cord-350569-dtxtjtfo | If indeed humans are self- rulers and rational players, why should social stigma prevent them from making self- rational and moral decisions in directing their own HIV medical therapy for their own good, and direct their lives as they deem fit? |
| cord-350569-dtxtjtfo | If to be autonomous is to be self- governing or self- directing or, in other words, to act on motives, values, and reasons that are one's own, then how can we restrict non- autonomous action to only false/ oppressive socialisation? |
| cord-350569-dtxtjtfo | Is this not conceptually and practically conflicting? |
| cord-350569-dtxtjtfo | Or there is n't a need to rethink because humans are, as Kantian and related notions of autonomy tell us, normatively and narratively sovereign selves? |
| cord-350569-dtxtjtfo | Therefore, does this temptation and pursuit to view ourselves as autonomous HIV testing decision- makers blind us to an observable reality that shows that as humans we are interdependent and inextricably social and socialised beings? |
| cord-350569-dtxtjtfo | Thus, can Killmister convincingly enumerate in what circumstances exactly an agent can enjoy this limited autonomy, circumstances which are excluded from the susceptibility to socialisation, internalisation, biological influences or environmental changes? |
| cord-350569-dtxtjtfo | Thus, should there be a need to rethink the personal autonomy 1 premising of informed consent requirements in HIV testing in most sub- Saharan African( SSA) countries, since informed consent requirements in HIV testing are mainly premised on personal autonomy? |
| cord-350569-dtxtjtfo | What about Christman's theory of autonomy which Killmister claims is more persuasive? |
| cord-350569-dtxtjtfo | Why should patients be declared and imputed with personal autonomy and yet at the same time blame the impact of social stigma on preventing potential HIV service- users from seeking medical attention? |
| cord-332610-t99l3zii | How do emerging diseases come to be categorized as'emerging'? |
| cord-332610-t99l3zii | If certain populations have long been afflicted by these disorders, why are the diseases considered''new''or''emerging''? |
| cord-332610-t99l3zii | If this is the case, what is the concern over avian influenza? |
| cord-332610-t99l3zii | In his critical analysis of emerging infection, Farmer asks,''Emerging for whom?'' |
| cord-332610-t99l3zii | Is it simply because they have come to afflict more visible-read more''valuable''persons? |
| cord-332610-t99l3zii | Nor does it answer the question''what drives the overall worldwide trends in such problems?'' |
| cord-332610-t99l3zii | Should toxic shock syndrome be considered to be an emerging disease? |
| cord-332610-t99l3zii | The 1969 outbreak was publicized in the United States through the news media, perhaps because it was an'exotic'or newsworthy event, and once again, the social amplification of risk was responsible for exaggerated fears of'what if it spreads here?' |
| cord-332610-t99l3zii | not answer either the micro- scale questions such as''why is there an outbreak here, now, of this size, affecting these people?''nor does it answer the macro- questions such as''why are there more( or fewer) outbreaks this decade than last?'' |
| cord-332610-t99l3zii | not answer either the micro- scale questions such as''why is there an outbreak here, now, of this size, affecting these people?''nor does it answer the macro- questions such as''why are there more( or fewer) outbreaks this decade than last?'' |
| cord-000333-4prvgmvt | : What's in a word? |
| cord-000333-4prvgmvt | How could you fail to thrive and develop as a new Faculty member under such inspiring and utterly humane leadership? |
| cord-000333-4prvgmvt | Is Toni Hoffmann a 21 st Century nurse hero? |
| cord-000333-4prvgmvt | Is heroism a legitimate part of nursing, or are nurses simply'just doing their job'even when facing extreme personal danger? |
| cord-000333-4prvgmvt | The business of Nursing? |
| cord-000333-4prvgmvt | The lessons of SARS Duty of Care or Medical Heroism? |
| cord-000333-4prvgmvt | Was this heroism and heroic actions on their part, or were they'just doing their job'? |
| cord-000333-4prvgmvt | What of the other contemporary meaning of heroism and heroes? |
| cord-000333-4prvgmvt | Who are our nursing heroes? |
| cord-000333-4prvgmvt | Who are the heroes on your list and why? |
| cord-000333-4prvgmvt | Who are the nursing giants upon whose shoulders we have stood and who continue to inspire us today? |
| cord-000333-4prvgmvt | Who are the nursing heroes that we tell our students about so that they can understand the best of Nursing's history? |
| cord-000333-4prvgmvt | Who are they to emulate if they want to be the best nurse possible? |
| cord-000333-4prvgmvt | [ 24] Would Emergency Department nurses see themselves as'heroes'? |
| cord-329890-wg23sa1u | Belief in effective HIV/ AIDS prevention"Is there an effective way of protecting yourself from AIDS"? |
| cord-329890-wg23sa1u | I ascertained perceived severity of HIV/ AIDS in terms of the respondents'subjective perception of the likelihood of death using the close- ended question"When you think about AIDS, how serious do you feel it is? |
| cord-329890-wg23sa1u | I include social constructs from the HBM and the SCT and some relevant contextual social factors, to explore the research question"What can we learn from the SARS experience about effective prevention of HIV/ AIDS"? |
| cord-329890-wg23sa1u | In the case of epidemics, competence is typically found at the community level and this brings us to the question of governance: how does a government deal with the health crisis represented by an infectious disease epidemic? |
| cord-329890-wg23sa1u | In the study of SARS, perceived susceptibility was ascertained through the question"How likely do you think it is for you to contract SARS"? |
| cord-329890-wg23sa1u | More specifically, why were the efforts to contain and prevent the spread of a new epidemic like SARS successful while it has taken 25 years so far to contain the spread of HIV/ AIDS and no effective solution is yet in sight? |
| cord-329890-wg23sa1u | Referring the respondents to the measures implemented to prevent the spread of SARS, they were asked their level of agreement( strongly agree to strongly disagree) with these statements:"People should be willing to make some personal sacrifices";"People have mostly been socially responsible";"If you did not develop symptoms of SARS after having close contact with someone diagnosed with SARS, would you agree to be quarantined for 10 days?";"If you did not develop symptoms of SARS after having non- close contact with someone diagnosed with SARS, would you agree to be quarantined for 10 days"? |
| cord-329890-wg23sa1u | Referring the respondents to the measures implemented to prevent the spread of SARS, they were asked their level of agreement( strongly agree to strongly disagree) with these statements:"People should be willing to make some personal sacrifices";"People have mostly been socially responsible";"If you did not develop symptoms of SARS after having close contact with someone diagnosed with SARS, would you agree to be quarantined for 10 days?";"If you did not develop symptoms of SARS after having non- close contact with someone diagnosed with SARS, would you agree to be quarantined for 10 days"? |
| cord-329890-wg23sa1u | The main research question is: what can we learn from the SARS experience about effective prevention of HIV/ AIDS? |
| cord-329890-wg23sa1u | The perceived severity of HIV/ AIDS was ascertained through the question"When you think about AIDS, how serious do you feel it is? |
| cord-329890-wg23sa1u | The perception of severity of SARS was measured by the question"If you have contracted SARS, what is the likelihood of survival"? |
| cord-329890-wg23sa1u | The public image of HIV/ AIDS was ascertained through one open- ended question about persons living with HIV/ AIDS:"What kind of people do you think are most likely to get AIDS"? |
| cord-329890-wg23sa1u | WHO global conference on severe acute respiratory syndrome( SARS)-where do we go from here? |
| cord-329890-wg23sa1u | What can we learn from the SARS experience about effective prevention of HIV/ AIDS? |
| cord-329890-wg23sa1u | What kind of people do you think are most likely to get HIV/ AIDS?" |
| cord-329890-wg23sa1u | When does the problem begin and when does it end and who is involved? |
| cord-329890-wg23sa1u | Would people's sense of susceptibility to these diseases and their severity contribute to that difference? |
| cord-270726-w59fu9c9 | As treatment of HIV has improved, the increase in peripheral CD4? |
| cord-270726-w59fu9c9 | Clostridium difficile is more common in patients with advanced AIDS( CD4? |
| cord-270726-w59fu9c9 | Data from simian models with simian immunodeficiency virus[ 16] and from patients with HIV[ 13, 17, 18] show that within weeks of infection, the vast majority of mucosal lamina propria CD4? lymphocytes are depleted. |
| cord-270726-w59fu9c9 | Diarrhea- associated HIV-1 APIs potentiate muscarinic activation of Cl- secretion by T84 cells via prolongation of cytosolic Ca2? |
| cord-270726-w59fu9c9 | Further, despite the use of potent antiretroviral medications, HIV persists within GALT lymphocytes, even after repletion of CD4? |
| cord-270726-w59fu9c9 | Imodium A- D, and Imodium multi- symptom relief( loperamide and loperamide- simethicone) PA: McNeil Consumer Healthcare Crofelemer for the treatment of secretory diarrhea Efficacy and safety of crofelemer for noninfectious diarrhea in HIV- seropositive individuals( ADVENT trial): a randomized, double- blind, placebocontrolled, two- stage study Population pharmacokinetic( PK) analysis demonstrates no drug- drug interactions( DDI) between crofelemer, a novel treatment for noninfectious diarrhea in HIV? |
| cord-270726-w59fu9c9 | In addition to these pathogens, patients with HIV who are profoundly immunosuppressed, with a CD4? |
| cord-270726-w59fu9c9 | In addition, crofelemer has no known drug interactions with ART drugs, is minimally absorbed, and does not have a negative impact on the clinical immune parameters( e.g., HIV viral load and CD4? |
| cord-270726-w59fu9c9 | In support of this assertion, US historical data of HIV- infected patients with CD4? |
| cord-270726-w59fu9c9 | Laboratory tests should include comprehensive metabolic panel, complete blood count with cell differential, blood cultures, HIV viral load, and CD4? |
| cord-270726-w59fu9c9 | Mycobacterium avium complex( MAC) typically causes diarrhea in patients with AIDS with profoundly suppressed immune systems( i.e., CD4? |
| cord-270726-w59fu9c9 | T cell depletion and viral replication in SIV infection Primary HIV-1 infection is associated with preferential depletion of CD4? |
| cord-270726-w59fu9c9 | T cells but is overpopulated with CD8? |
| cord-270726-w59fu9c9 | T cells is seen in the periphery and likely reflects the greater expression of the CC chemokine receptor type 5( CCR5), which functions as the primary coreceptor for the majority of infective HIV strains, on mucosal CD4? |
| cord-270726-w59fu9c9 | T lymphocytes from effector sites in the gastrointestinal tract Mechanisms of gastrointestinal CD4? |
| cord-270726-w59fu9c9 | The expression of the chemokine receptor on these cells supports the entry of the virus, but their state of physiologic activation is responsible for enhanced HIV replication in the mucosal compartment and subsequent mucosal CD4? |
| cord-270726-w59fu9c9 | The mucosal immune system and HIV-1 infection Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissueinfiltrating lymphocytes Gastrointestinal tract as a major site of CD4? |
| cord-270726-w59fu9c9 | This depletion occurs well before any decrease in CD4? |
| cord-270726-w59fu9c9 | This reflects greater mucosal infiltration by activated CD8? |
| cord-270726-w59fu9c9 | Thus, in patients with chronic HIV infection, the mucosal environment contains a paucity of CD4? |
| cord-340489-yo3cp5vs | Auf Befragen gibt er an Welche Frage ist zunächst zu stellen? |
| cord-340489-yo3cp5vs | Ist die Candidapneumonie eine häufige Erkrankung? |
| cord-340489-yo3cp5vs | Sie zunächst? |
| cord-340489-yo3cp5vs | Sprosspilzinfektionen endogen oder exogen erworben? |
| cord-340489-yo3cp5vs | Untersuchung veranlasst? |
| cord-340489-yo3cp5vs | Was empfehlen Sie dem Patienten? |
| cord-340489-yo3cp5vs | Welche sind die 3 wichtigsten Antimykotika- Substanzklassen? |
| cord-340489-yo3cp5vs | Welche therapeutischen Maßnahmen sind angezeigt? |
| cord-340489-yo3cp5vs | Werden Fadenpilzinfektionen endogen oder exogen erworben? |
| cord-340489-yo3cp5vs | Wie lautet Ihre Verdachtsdiagnose? |
| cord-340489-yo3cp5vs | Wie soll man HIV- infizierte Schwangere behandeln? |
| cord-340489-yo3cp5vs | Wie wird der Patient initial behandelt? |
| cord-340489-yo3cp5vs | Windpockenerkrankungen oder eine Gingivostomatitis herpetica behandelt werden? |
| cord-340489-yo3cp5vs | b. Welche Untersuchungen werden durchgeführt? |
| cord-340489-yo3cp5vs | c. Wie wird der Patient behandelt? |
| cord-340489-yo3cp5vs | d. Was wird dem Patienten gesagt? |
| cord-340489-yo3cp5vs | einer antiretroviralen Therapie bei HIV- Infektion? |
| cord-340489-yo3cp5vs | oder häufig gegen Fluconazol resistent? |
| cord-340489-yo3cp5vs | unteren Atemwege mit Candida species? |
| cord-340489-yo3cp5vs | unterschieden? |
| cord-340489-yo3cp5vs | werden? |
| cord-340489-yo3cp5vs | werden? |
| cord-002774-tpqsjjet | ( 2) does participation in drug treatment programs increase social capital?, and( 3) is there a significant difference among treatment modalities in affecting change in~ial capital? |
| cord-002774-tpqsjjet | ( 2) does participation in drug treatment programs increase social capital?, and( 3) is there a significant difference among treatment modalities in affecting change in~ial capital? |
| cord-002774-tpqsjjet | Die: How to Save our Children? |
| cord-002774-tpqsjjet | Findings suggest that HM have less access t? |
| cord-002774-tpqsjjet | How can we Measure this Elusive Goal? |
| cord-002774-tpqsjjet | How do AIDS mortality and fatality rates vary when related community characteristics, such as household income, ethnic mix, and geographic access to primary and ancillary HIV/ AIDS services are considered? |
| cord-002774-tpqsjjet | How has the widespread availability of HAART( after 1996) impacted AIDS outcomes at the community level? |
| cord-002774-tpqsjjet | However, as part of an ongoing study? |
| cord-002774-tpqsjjet | In June 2004, the Association of? |
| cord-002774-tpqsjjet | Moreover, there is n? basis for assessing the impact of the resultant initiatives to improve health~onditions amo~ g~o":1":1um ties settled in unplanned areas. |
| cord-002774-tpqsjjet | Nearly all participants( 97%) reported a history of contact with drug llt.lnnent services( methadone maintenance, rehabilitation clinics and judicial treatment), mental health car? |
| cord-002774-tpqsjjet | Since urban areas are more than the aggregation? |
| cord-002774-tpqsjjet | System for Homeless, HIV- infected Patients in NYC? |
| cord-002774-tpqsjjet | The increase m parnc1pat10n, the CHR mvolvement in the community, and the positive feedback from the agen? |
| cord-002774-tpqsjjet | The moot question in all the above observed development are: has the city rationally addressed it planning needs? |
| cord-002774-tpqsjjet | The principle research questions were: 1) What is the relationship between the locations of areas with concentrations of PL WA and the distribution of both primary and ancillary service providers? |
| cord-002774-tpqsjjet | The quesuon to be explore.cl 1~: If health care is available and accessible to one person, what makes it not available to all people? |
| cord-002774-tpqsjjet | The research questions were: What are the effects of homelessness on health? |
| cord-002774-tpqsjjet | Two research questions were investigated: are there spatial patterns to the events dis · tribution, and moreover, are these patterns overlapping across space? |
| cord-002774-tpqsjjet | What kind of supports are needed for homeless people to get off the street? |
| cord-002774-tpqsjjet | When the govern · ment withdrew from direct service provision as reform trends and donor advocacy suggested, how does it perform its new indirect role of managing relations with new direct health services providers in terms of regulating, enabling, and managing relations with these health services providers? |
| cord-002774-tpqsjjet | When/(calen · dar time), By 2, fisher exact and t were appliedxwhom( authors?). |
| cord-002774-tpqsjjet | Who and Why? |
| cord-002774-tpqsjjet | Why children die in Bangladesh? |
| cord-002774-tpqsjjet | _ contacts these women via? |
| cord-002774-tpqsjjet | a report of the efforts being made towards such a goal: The paper descr~ bes~ c~ se study? |
| cord-002774-tpqsjjet | and dent~ I hygiene t? |
| cord-002774-tpqsjjet | blocks, we considered a broad range of factors including evidence of homogeneity an~ heterogeneity( socmeconomic, ethnic, housing type, environmental) across blocks within and blocks ad1acent to a nei.ghborhood, and across the 36 sample neighborhoods; the potential for efficient recruit · ment of appropriate particip.ants( i.e. sufficient local pedestrian traffic); and boundaries used in reporting census data( s? |
| cord-002774-tpqsjjet | cQue tenemos para aprender de las"soluciones"que ellos mismos encuenrran a los usos problemat1cos? |
| cord-002774-tpqsjjet | dema~~a? |
| cord-002774-tpqsjjet | en estas comunidades? |
| cord-002774-tpqsjjet | t) does social capital predict parti~ ipating in treatment programs? |
| cord-002774-tpqsjjet | to all pama~~g? |
| cord-002774-tpqsjjet | ~i~ an~ s were recruited from drop in centres in 7 cities across |
| cord-002774-tpqsjjet | ~ts: In addmon to reporting process data and descriptions of the SIF users, we report on data indicating that the establishment of the SIF has been independently associated with reductions in public~': ° g~( p |